期刊文献+

Ck2α、β-catenin和survivin在卵巢癌组织中表达的检测及其临床应用价值 被引量:3

Detection of expressions of Ck2α,β-catenin and survivin in ovarian cancer tissue and its clinical application value
下载PDF
导出
摘要 目的:研究酪蛋白激酶2α(Ck2α)、β-catenin和survivin在卵巢癌组织中的表达情况,分析三者在卵巢癌中表达的相关性,探讨其临床应用价值。方法:采用免疫组织化学法检测8例卵巢单纯性囊肿组织、8例卵巢良性肿瘤组织和29例卵巢癌组织中Ck2α、β-catenin和survivin的表达情况,分析3种蛋白在卵巢癌中表达的相关性及与患者临床病理特征的关系。结果:与卵巢单纯性囊肿和良性卵巢肿瘤组织比较,卵巢癌组织中Ck2α、β-catenin和survivin蛋白表达水平明显升高(P<0.05);卵巢癌组织中Ck2α与β-catenin和survivin表达水平呈正相关关系(r=0.438和r=0.479,P<0.05);在不同分化程度卵巢癌组织中,与低-中分化组比较,高分化组Ck2α、β-catenin和survivin蛋白阳性表达率明显降低(P<0.05);不同FIGO分期中,与Ⅰ期组比较,Ⅱ期组和Ⅲ期组Ck2α、β-catenin和survivin蛋白阳性表达率升高,3组间比较差异有统计学意义(P<0.05)。结论:Ck2α、β-catenin和survivin在卵巢癌组织中的蛋白表达水平增加,且三者呈正相关,可能与卵巢癌的发生发展有关;Ck2α、β-catenin和survivin三者联合检测具有重要的临床应用价值。 Objective To study the expressions of casein kinase 2α(Ck2α),β-catenin, survivin in ovarian cancer tissue and analyze the relationships between them, and to explore the clinical application value. Methods Immunohistochemistry staining was used to detect the expressions of Ck2α,β-catenin and survivin in 8 cases of simple ovarian cysts tissue,8 cases of ovarian benign tumor tissue and 29 cases of ovarian cancer tissue;the correlations of the expressions of Ck2α,β-catenin,survivin in ovarian cancer tissue and their associations with the clinicopathologic characteristics were analyzed.Results The expression levels of Ck2α,β-catenin and survivin in ovarian cancer tissue were significantly higher than those in simple ovarian cysts tissue and ovarian benign tumor tissue(P〈0.05);the Ck2αexpression level in ovarian cancer tissue was positively corelated with the expression&amp;nbsp;levels ofβ-catenin and survivin(r=0.438,r=0.479,P〈0.05);the expression levels of Ck2α,β-catenin and survivin in low-medium differentiation group were significantly higher than those in high differentiation group (P〈0.05);the expression levels of Ck2α,β-catenin and survivin in stagesⅡandⅢ group were significantly higher than those in stage Ⅰ group(P〈0.05).Conclusion The protein expression levels of Ck2α,β-catenin and survivin are increased in ovarian cancer tissue, and three are positive corelations between them;Ck2α,β-catenin and survivin may play an important role in the occurrence and development of ovarian cancer;the combined detection of them has important clinical value.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2014年第6期1256-1260,1337,共6页 Journal of Jilin University:Medicine Edition
基金 辽宁省科技厅自然科学基金资助课题(2013225305)
关键词 酪蛋白激酶2α 卵巢肿瘤 CASEIN KINASE β-catenin survivin β-catenin survivin ovarian neoplasms
  • 相关文献

参考文献4

二级参考文献47

共引文献20

同被引文献40

  • 1周琦,叶学正,唐郢.survivin与宫颈癌前病变及宫颈癌关系的研究[J].重庆医学,2006,35(5):427-429. 被引量:3
  • 2Filhol O, Cochet C. Protein kinase CK2 and cancer: fur- ther clues are accumulating [ J 1 Bull Cancer, 2002,89 (3) :261-265.
  • 3Morin P J. beta-eatenin signaling and cancer[ J]. Bioes- says, 1999,21 (12) :1021-1030.
  • 4Lee J P, Chang K H, Han J H, et al. Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors [ J ]. Int J Gynecol Cancer, 2005,15( 1 ) :113-119.
  • 5Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[ J]. Int J Gynaecol Ob- stet, 2009,105 ( 2 ) : 103 -104.
  • 6Faust R A, Niehans G, Gapany M, et al. Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells [ J]. Int J Biochem Cell Biol, 1999,31 (9) :941-949.
  • 7Trembley J H, Wang G, Unger G, et al. Protein kinase CK2 in health and disease: CK2: a key player in cancer bi- ology [ J ]. Cell Mol Life Sci, 2009,66 ( 11-12 ) : 1858-1567.
  • 8Chakraborty A, Werner J K, Koldobskiy M A, et al. Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2 [ J ]. Proc Nat1 Acad Sci U S A. 2011.108(6) ,2205-2209.
  • 9郑力强,韩向春,张凯.阴茎鳞癌中survivin和caspase-3蛋白的表达及其与腹股沟淋巴结转移的关系[J].西北国防医学杂志,2010,31(2):114-116. 被引量:3
  • 10宋誌.单纯子宫内膜异位症与合并卵巢癌的临床分析[J].天津医药,2010,38(10):916-917. 被引量:4

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部